COR2ED brings you Independent Medical Education from OBSTETRICS & GYNECOLOGY CONNECT, experts in obstetrics & gynecology https://xitter.gq/t.co/ggOUJv0i5c
Joined November 2022
- Tweets293
- Following448
- Followers2.6K
- Likes49
OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED retweeted
Check out our Collaborators at COR2ED and this EXPERT insights from #ESMO26
GI oncologists Dr Lizzy Smyth, Dr Yelena Janjigian and Assoc. Prof. Gerald Prager join COR2ED at ESMO 2026 to provide their instant reactions on new data presented at the meeting. While Drs Smyth and Janjigian discuss gastric/GEJ cancer developments, Dr Prager will be focusing on colorectal and pancreatic cancer. @LizzySmyth1, @YJanjigianMD
cor2ed.com/esmo-2026/gastric…
OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED retweeted
🎙️ ESMO 2026: Expert insights in NSCLC
Our Collaborators at @COR2EDMedEd met with medical oncologist Dr Louise Lim at ESMO 2026 , to discuss the latest non-small cell lung cancer (NSCLC) data and what it could mean for clinical practice. 👉 cor2ed.com/highlights-from-e…
🔬 Key studies in focus:
▪️ KRAS G12C: KRAScendo 1 (LBA5)
▪️ EGFR-mutated, MET-driven NSCLC: SAFFRON (LBA6)
▪️ First-line PD-L1-negative NSCLC: OptiTROP-Lung06 (LBA66)
▪️ EGFR-mutated NSCLC post-TKI: OptiTROP-Lung04 (LBA67)
Join us for expert perspectives on these emerging data and their potential implications for treatment decisions.📍 Recorded at ESMO 2026
#ESMO26 #LungCancer
OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED retweeted
🎥 #ESMO26 highlights from our collaborators @COR2EDMedEd Visit them at the main exhibition hall to learn more
Watch Here👉 buff.ly/HBEGYqU
Leading experts give quick takes on the key data, ~3 min per tumour type:
🔹 Gastric/GEJ: Smyth & Janjigian
🔹 CRC & pancreatic: Prager
🔹 HCC: Chon & Rimassa
🔹 NSCLC: Newsom-Davis & Lim
🔹 Breast: Jhaveri
🔹 GU: Iacovelli
@YJanjigianMD, @tnewsomdavis, @LorenzaRimassa, @jhaveri_komal, @DrIacovelli @COR2EDMedEd
OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED retweeted
Drs @jhaveri_komal and @DrIacovelli are joining our collaborators at COR2ED at ESMO 2026 to share their thoughts on the latest data presented at the meeting. Dr Jhaveri will provide insights on #BreastCancer 🇺🇸 data, while Dr Iacovelli 🇮🇹 will review developments in #ProstateCancer and #BladderCancer
👉 Explore the coverage cor2ed.com/highlights-from-e…
OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED retweeted
🚨 #ESMO26 GU Oncology — Top picks by OncoAlert 🎯
#BladderCancer : VOLGA, KEYNOTE-B15, ENERGIZE, KEYNOTE-866
#ProstateCancer: DASL-HiCaP, CAPItello-281, PROTEUS
#KidneyCancer: LITESPARK-011 & -012, ivonescimab, PE-PE, SWOG S2200, XmAb819
Our Participating Faculty
@DrChoueiri, @tompowles1, @apolo_andrea, @neerajaiims, @montypal, @Silke_Gillessen, @AOmlin, @brian_rini, @PGrivasMDPhD, @TiansterZhang, @amerseburger , @DrDanielHeng, @HHammersMD, @scocmem, @AndreaNecchi , @AmandaNizamMD, @drenriquegrande, @nataliagandur
@AlbigesL, @cdanicas, @declangmurphy, @seanmmcbride, @shilpaonc, @DrRanaMcKay, @scserendipity1, @DrYukselUrun , @ravikanesvaran , @BraunMDPhD, @EfstathiouEleni, @mzugman , @crisbergerot, @ElisaAgostinett, @to_be_elizabeth, @MarioBalsaMD, @BRicciutiMD, @HHorinouchi, @UOzkerim, @p_ciracimd, @DrMirallas , @sonpavde , @Dr_Oncologista
Understanding HER2 testing in gynecological cancers: best practice & treatment implications
w/ expert pathologist Prof. Fernando Soares
📺 Video in this post
View/download the slides for more details: cor2ed.com/precision-oncolog…
Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.
#MedEd #obgyn #OncTwitter #precisionmedicine
Precision oncology in gynecological cancers – a MedEd programme for HCPs
📺 Explore HER2 testing in endometrial, cervical & ovarian cancers
>> Guideline-based overview, best practice & treatment implications
w/ Prof. Fernando Soares
cor2ed.com/precision-oncolog…
Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.
#MedEd #obgyn #OncTwitter #precisiononcology
Exploring best practice in HER2 testing in gynecological cancers
What are the guidelines around HER2 IHC testing & scoring in endometrial, cervical & ovarian cancers?
How does HER2 status impact treatment selection?
Prof. Fernando Soares answers these questions in a guideline-based overview
📺 Video in this post
🔗 Slides >> cor2ed.com/precision-oncolog…
Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.
#MedEd #obgyn #OncTwitter #precisiononcology
New video!
Understanding HER2 testing in gynecological cancers
Prof. Fernando Soares provides a guideline-based overview 📺
Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.
How should treatment selection in advanced endometrial cancer be informed?
Prof. Domenica Lorusso explores ESGO guidance, molecular subtypes, and the role of chemotherapy-immunotherapy and chemotherapy-free approaches in clinical practice
#MedEd
Optimising treatment selection in advanced endometrial cancer
📺 Expert video from Prof. Domenica Lorusso
Explore ESGO guidelines & what they mean for clinical practice
-Clinical relevance of molecular subtypes/their role in risk stratification & treatment planning
-Tx algorithms for advanced/recurrent disease, inc. distinctions between dMMR/non-dMMR tumours
-pembrolizumab + lenvatinib as a chemotherapy-free option for selected pts
-Established systemic treatment strategies across molecular subgroups
View the slides: cor2ed.com/obstetrics-gyneco…
🤝 Programme endorsed by @WarOnCancer
Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content
#MedEd #obgyn #OncTwitter
📣 New video!
Understanding HER2 testing in gynecological cancers
Prof. Fernando Soares provides a guideline-based overview 📺
View/download the slides for more details: cor2ed.com/precision-oncolog…
Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.
#MedEd #obgyn #MedTwitter #precisionmedicine
As HER2-targeted treatment options continue to expand in gynaecological cancers.
Prof. Fernando Soares provides practical guidance on HER2 IHC testing, scoring, and how HER2 status can inform treatment decisions.
#MedEd
➡️ HER2 IHC testing is recommended in p53-aberrant endometrial carcinoma
➡️ It may be considered in selected advanced/recurrent cervical & ovarian cancers when evaluating eligibility for HER2-targeted therapies
🧬 Find out more about #HER2 testing in gynecological cancers, best practice, & treatment selection
📺 From Prof. Fernando Soares
Get the slides for more: cor2ed.com/precision-oncolog…
Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.
#MedEd #obgyn #MedTwitter #precisionmedicine
➡️ HER2 IHC testing is recommended in p53-aberrant endometrial carcinoma
➡️ It may be considered in selected advanced/recurrent cervical & ovarian cancers when evaluating eligibility for HER2-targeted therapies
🧬 Find out more about #HER2 testing in gynecological cancers, best practice, & treatment selection
📺 From Prof. Fernando Soares
Get the slides for more: cor2ed.com/precision-oncolog…
Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.
#MedEd #obgyn #MedTwitter #precisionmedicine
📺 Endometrial cancer update from Prof. Domenica Lorusso
✔️ Navigating recent ESGO guidelines
✔️ Implications for clinical practice
What do HCPs need to know about treatment selection in advanced endometrial cancer?
📺 Watch the video to find out!
View the slides: cor2ed.com/obstetrics-gyneco…
🤝 Programme endorsed by @WarOnCancer
Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content
#MedEd #MedTwitter #endometrialcancer
Understanding HER2 testing in gynecological cancers: Best practices and treatment implications
✔️ Get a guideline-driven overview of immunohistochemistry testing in endometrial, cervical & ovarian cancers
✔️ Find out why accurate assessment is now critical for treatment selection
📺 From Prof. Fernando Soares
Get the slides for more details: cor2ed.com/precision-oncolog…
Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.
#MedEd #obgyn #MedTwitter
Optimising treatment selection in advanced endometrial cancer
📺 Expert video from Prof. Domenica Lorusso
Explore ESGO guidelines & what they mean for clinical practice
-Clinical relevance of molecular subtypes/their role in risk stratification & treatment planning
-Tx algorithms for advanced/recurrent disease, inc. distinctions between dMMR/non-dMMR tumours
-pembrolizumab + lenvatinib as a chemotherapy-free option for selected pts
-Established systemic treatment strategies across molecular subgroups
View the slides: cor2ed.com/obstetrics-gyneco…
🤝 Programme endorsed by @WarOnCancer
Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content
#MedEd #obgyn #OncTwitter
Precision oncology in gynecological cancers – a MedEd programme for HCPs
📺 Explore HER2 testing in endometrial, cervical & ovarian cancers
>> Guideline-based overview, best practice & treatment implications
w/ Prof. Fernando Soares
Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.
Precision oncology in gynecological cancers – a MedEd programme for HCPs
📺 Explore HER2 testing in endometrial, cervical & ovarian cancers
>> Guideline-based overview, best practice & treatment implications
w/ Prof. Fernando Soares
cor2ed.com/precision-oncolog…
Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.
#MedEd #obgyn #OncTwitter #precisiononcology
OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED retweeted
HER2 testing is recommended in range of gynecological cancers.
Prof. Fernando Soares shares a practical, guideline-based overview of HER2 IHC testing and scoring across endometrial, cervical & ovarian cancers, and what it means for treatment selection.
📷 Watch the full video here:
cor2ed.com/precision-oncolog…
Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.
#MedEd #GynecologicOncology #PrecisionMedicine
